ライフサイエンスコーパス: chest discomfort

1 ) reported atypical, non-limiting persistent chest discomfort.

2 oracentesis does not alter procedure-related chest discomfort.

3 imilar to patients with noncardiac causes of chest discomfort (0.2%), and lower than T2MI2007 (3.6%)

4 common symptoms include palpitations (86%), chest discomfort (47%), and dyspnea (38%).

5 Only 29.7% reported chest discomfort, a hallmark symptom in men.

6 patients to triage patients presenting with chest discomfort after PCI.

7 illation, adverse cardiovascular events, and chest discomfort after the procedure.

8 The presence of chest discomfort and a history of mechanical revasculari

9 nosine (Ado) to patients can cause dyspnoea, chest discomfort and bronchoconstriction.

10 lso developed patient education videos about chest discomfort and heart failure.

11 serious AEs in 4 subjects and 2 serious AEs [chest discomfort and increased heart rate, without cardi

12 PCI readmission is associated with low-risk chest discomfort and patient anxiety.

13 Chest discomfort at rest is the most common presenting s

14 se important symptoms, such as palpitations, chest discomfort, breathlessness, anxiety, and syncope,

15 clear stridor and show prolonged coughs and chest discomfort caused by small-airways dysfunction hav

16 inical course was uneventful, no patient had chest discomfort, coughing, or hemoptysis.

17 Remote IPC reduces ischemic chest discomfort during PCI, attenuates procedure-relate

18 the FFR group than in the iFR group reported chest discomfort during the procedure.

19 ropic effect (A-H interval prolongation) and chest discomfort experienced during infusion of adenosin

20 tension presented with various symptoms like chest discomfort, fatigue, dizziness, atrial fibrillatio

21 oson was well-tolerated; side effects (e.g., chest discomfort, flushing, dyspnea) were generally mild

22 The primary outcome was overall chest discomfort from before the start to after the proc

23 eural fluid if patients developed persistent chest discomfort, intractable cough, or other complicati

24 oronary syndrome in patients presenting with chest discomfort is a challenge.

25 no difference in the rating of postprocedure chest discomfort (median in both groups = 0 of 10; P = .

26 o study-group assignment, were asked to rate chest discomfort on 100 mm visual analogue scales before

27 cts who received remote IPC experienced less chest discomfort (P=0.0006) and ECG ST-segment deviation

28 e pleural pressure, which is associated with chest discomfort, pneumothorax, and re-expansion pulmona

29 for the primary outcome (mean difference in chest discomfort score 2.4 mm, 95% CI -5.7 to 10.5, p=0.

30 Among 6253 patients with acute chest discomfort, the final adjudicated diagnosis was T2

31 te myocardial injury in the setting of acute chest discomfort-thus providing more rapid evaluation fo

32 management of patients presenting with acute chest discomfort to the ED.

33 n consecutive patients presenting with acute chest discomfort to the emergency department (ED) and en

34 udy enrolling patients presenting with acute chest discomfort to the emergency department (ED), the a

35 Adult patients presenting with acute chest discomfort to the emergency department were enroll

36 Patients presenting with acute chest discomfort to the emergency department were prospe

37 epublic) with patients presenting with acute chest discomfort to the emergency departments.

38 Chest discomfort was reduced in 82 of the 84 patients.

39 s, unselected patients presenting with acute chest discomfort were enrolled from April 2006 to April

40 ssible cardiovascular involvement, including chest discomfort with electrocardiographic changes, acut

41 hmatic patients who had prolonged coughs and chest discomfort with the middle or high dose of ICS/LAB